Villamor, Erlinda N.
HRN: 20-49-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
12/01/2022
12/07/2022
IV
500mg
OD
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes